Founded in 2014 and headquartered in Princeton, New Jersey, Asana BioSciences, LLC is a research and development company specializing in the discovery and development of new chemical and biological entities. Led by Dr. Sandeep Gupta, Asana’s portfolio consists of multiple early-stage drug discovery and development candidates in a variety of therapeutic areas, including oncology, pain and inflammation, among others. The company’s lead product is ASN-002, a novel dual SYK / JAK inhibitor focused on dermatological indications. ASN-002 is currently in PII for atopic dermatitis.